About Strand Therapeutics
Strand Therapeutics is a company based in Cambridge (United States) founded in 2017 by Tasuku Kitada.. Strand Therapeutics has raised $103.14 million across 7 funding rounds from investors including Lilly, BeiGene and ARE. The company has 47 employees as of December 31, 2021. Strand Therapeutics offers products and services including Programmable mRNA Therapeutics and Self-Replicating mRNAs. Strand Therapeutics operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
- Headquarter Cambridge, United States
- Employees 47 as on 31 Dec, 2021
- Founders Tasuku Kitada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Strand Therapeutics Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$103.14 M (USD)
in 7 rounds
-
Latest Funding Round
-
Investors
Lilly
& 11 more
-
Employee Count
47
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Strand Therapeutics
Strand Therapeutics offers a comprehensive portfolio of products and services, including Programmable mRNA Therapeutics and Self-Replicating mRNAs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Creates mRNA with logic for targeted disease treatment
Develops replicating mRNA for long-acting medical effects
Unlock access to complete
Unlock access to complete
Funding Insights of Strand Therapeutics
Strand Therapeutics has successfully raised a total of $103.14M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Last Round
- First Round First Round
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Series B - Strand Therapeutics | Valuation |
investors |
|
| Nov, 2022 | Amount | Series A - Strand Therapeutics | Valuation | FPV Ventures | |
| Jun, 2021 | Amount | Series A - Strand Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Strand Therapeutics
Strand Therapeutics has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, BeiGene and ARE. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are provided to mission-driven founders by FPV Ventures.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on tech startups
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Strand Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Strand Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Strand Therapeutics Comparisons
Competitors of Strand Therapeutics
Strand Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Strand Therapeutics
Frequently Asked Questions about Strand Therapeutics
When was Strand Therapeutics founded?
Strand Therapeutics was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Strand Therapeutics located?
Strand Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Strand Therapeutics a funded company?
Strand Therapeutics is a funded company, having raised a total of $103.14M across 7 funding rounds to date. The company's 1st funding round was a Series A of $52.14M, raised on May 19, 2019.
How many employees does Strand Therapeutics have?
As of Dec 31, 2021, the latest employee count at Strand Therapeutics is 47.
What does Strand Therapeutics do?
Strand Therapeutics was founded in 2017 in Cambridge, United States. A programming platform is offered in the biotechnology sector to deliver mRNA therapeutics for multi-functional applications. Locations are detected and protein expression is enhanced in specific cell types within the patients body to support immunotherapy optimization. Services emphasize targeted treatments in oncology and related fields.
Who are the top competitors of Strand Therapeutics?
Strand Therapeutics's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Strand Therapeutics offer?
Strand Therapeutics offers Programmable mRNA Therapeutics and Self-Replicating mRNAs.
Who are Strand Therapeutics's investors?
Strand Therapeutics has 12 investors. Key investors include Lilly, BeiGene, ARE, HHS, and FPV Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.